Federal Issues
The Massachusetts Biotechnology Council is front and center on Capitol Hill when it comes to pushing policies that will pave the way for innovation. We fight for the laws and regulations that will speed the development of treatments and cures for Alzheimer's, Diabetes, HIV/AIDs and other ailments. We work for policies that will help bring those drugs to the market and make them available to all.
Strong government support will help foster research on human stem cells,
one of the most promising areas of research in the medical field today.
Read more
It is crucial to strengthen the existing patent system to attract
investors who can help the biotechnology industry to grow.
Read more
As biotechnology drugs hit the market, companies will look to copy them.
Appropriate regulations are needed to protect the health and safety of
consumers and encourage more development.
Read more
Prescription Drug User Fee Act (PDUFA)
The user fee program adopted by Food and Drug Administration has
significantly improved the efficiency of licensing drugs without
compromising safety.
Read more
Small Business Innovation Research Program (SBIR)
Access to these grants that provide significant assistance to small
companies working on critical research must be expanded to ensure a
stronger drug pipeline.
Read more
National Institutes of Health Funding
The funding provided by the National Institutes of Health enables basic research that provides the
fundamental building blocks for innovation.
Read more
The biotechnology industry in the United States is strong because the
nation has resisted the urge to adopt artificial price controls that
have hindered innovation elsewhere.
Read more
Strong federal policy is necessary to protect the safety of the American
public and ensure the strength of the U.S. market.
Read more
PHONE: 617.674.5100
EMAIL: